Lithium time-to-event trial in amyotrophic lateral sclerosis stops early for futility. Lancet Neurol.
PRIMARY NEWSPaper Alert: Lithium for ALS Deemed Futile, Study Stops Early
RELATED PAPERSSafety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
RELATED NEWSResearch Brief: Lithium for ALS—Another Nail in the Coffin